Silva FLF, Carrillo GV

Language: Spanish
References: 5
Page: 457-459
PDF size: 220.18 Kb.

ABSTRACT

The treatment of melanomas can include amputation of the affected limb, although this represents a significant decrease in the patient's functionality; isolated limb perfusion can be used for its prevention, in which antineoplastic treatment is administered. We present the case of a patient with recurrent melanoma who underwent isolated perfusion of the right limb and lymph node resection.

REFERENCES

1. Duarte C, García M, Lehmann C, Sánchez R, Manrique J. Perfusión aislada de extremidades. Experiencia inicial del Instituto Nacional de Cancerología, 2007-2008. Rev Colomb Cancerol. 2011; 15 (2): 67.74.

2. Cuellar-Guzmán LF, Ferretiz-López G, Cárdenas-Herrera N. Perioperative considerations in the oncologic patient undergoing isolated limb perfusion. Gac Mex Oncol. 2017; 16 (5): 281-286.

3. Niethard M, Fischer H, Gabmann B, Haralambiev L, Tipp A, Tunn PU. The use of regional anesthesia to reduce blood loss in isolated limb perfusion (ILP)-A novel approach. J Clin Med. 2023; 12 (20): 6542.

4. Ruschulte H, Shi S, Tseng WW, Kolodzie K, Crawford PC, Schneider DB et al. Anesthesia management of patients undergoing hyperthermic isolated limb perfusion with melphalan for melanoma treatment: an analysis of 17 cases. BMC Anesthesiol. 2013; 13 (1): 15. doi: 10.1186/1471-2253-13-15.

5. Gul Z, Bashir Q, Nieto Y, Sherwani N, Parmar S, Shah N et al. Cardiac toxicity after high-dose melphlan and autologous hematopoietic stem cell transplantation for multiple myeloma. Blood. 2012; 120 (21): 2027.